A comparative bioavailability study on two brands of cisapride tablets using univariate and multivariate statistical methods
![FDA Advisory No. 2020-1822 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products - Food and Drug Administration FDA Advisory No. 2020-1822 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products - Food and Drug Administration](https://www.fda.gov.ph/wp-content/uploads/2021/02/FDA-Advisory-No.2020-1822.png)
FDA Advisory No. 2020-1822 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products - Food and Drug Administration
![PDF) Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers | Robert Woestenborghs - Academia.edu PDF) Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers | Robert Woestenborghs - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/48496356/mini_magick20190203-4975-etlefy.png?1549225817)